Status:
COMPLETED
Management of Patients Suspected of COVID 19 With Ultra Low Dose Thoracic Scanner
Lead Sponsor:
Centre Hospitalier Universitaire de Nīmes
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
The year 2020 was marked by the emergence of a new respiratory disease: COVID19 related to an infection with the coronavirus SARS-CoV-2 (name given by the WHO on February 11, 2020). Initially appearin...
Detailed Description
Main objective To evaluate the diagnostic performance of ULD vs. LD scanning for the diagnosis of COVID-19 lung disease. Primary endpoint LD and ULD acquisitions will be anonymized and randomized in ...
Eligibility Criteria
Inclusion
- Patients having had the LD and ULD acquisitions
Exclusion
- scanner not passed through the COVID circuit, no ULD acquisition performed
Key Trial Info
Start Date :
March 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 5 2020
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04794361
Start Date
March 5 2020
End Date
May 5 2020
Last Update
March 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Julien FRANDON
Nîmes, France